Xue L

No ORCID on file · 14 papers in corpus · active 2021-2026

Study types

  • other 3
  • article 1
  • preprint 1

Condition tags

  • endometriosis 4
  • dysmenorrhea 1
2026
Endocrine connections ·doi:10.1530/ec-25-0830

BackgroundThe relationship between gonadotropin-releasing hormone agonists (GnRH-as) and depression and suicide/self-injury (DASSI) remains controversial. This study aimed to investigate this potential association using data from the FDA Ad…

other 2026
Nature aging ·doi:10.1038/s43587-026-01159-2

Recent studies have highlighted the crucial role of mechanical properties in the ovarian microenvironment for ovarian function. However, the mechanisms that cause ovarian matrix stiffening during aging remain incompletely understood. Here w…

2026
Biomarker research ·doi:10.1186/s40364-026-00914-2

High-throughput omics technologies have transformed our understanding of female reproductive biology, revealing molecular interactions governing oocyte maturation, ovarian reserve, endometrial receptivity, and embryo development, yet most f…

2025
Current urology ·doi:10.1097/cu9.0000000000000253

We introduced our experience for an innovative and effective approach for cervical canal penetration in patients diagnosed with type II vaginal atresia with adequate uterine corpus development. The uterine cavity and neovagina was connected…

other 2025
BMC women's health ·doi:10.1186/s12905-025-04097-0

BACKGROUND: Endometriosis is currently considered a chronic disease for which long-term medical treatment is needed. The aim of this study was to evaluate the long-term efficacy and safety of dydrogesterone in Chinese women with endometrios…

article 2025

Liqiu Xue,1 Rongjun Zhang,2 Jiaxing Chen,2 Xiaoxia Ge,3 Jiajing Chen4 1Department of Pathology, Jinjiang Hospital of Traditional Chinese Medicine, Jinjiang, Quanzhou, People’s Republic of China; 2Department of Pathology, Jinjiang Municipal …

2024
Nature aging ·doi:10.1038/s43587-024-00607-1

Limited understanding exists regarding how aging impacts the cellular and molecular aspects of the human ovary. This study combines single-cell RNA sequencing and spatial transcriptomics to systematically characterize human ovarian aging. S…

2023
Cancer medicine ·doi:10.1002/cam4.5804

BackgroundIncreasing attention has been paid to the survival of endometrial cancer (EC) patients, but the non-cancer causes of death from EC are rarely reported. This study primarily aimed to investigate the non-cancer causes of death in pa…

2022
Biomedicines ·doi:10.3390/biomedicines10081910

As a multifaceted adipokine, chemerin has been found to perform functions vital for immunity, adiposity, and metabolism through its three known receptors (chemokine-like receptor 1, CMKLR1; G-protein-coupled receptor 1, GPR1; C-C motif chem…

other 2021
PloS one ·doi:10.1371/journal.pone.0254142

INTRODUCTION: Uterine leiomyoma (UL) is a common benign pelvic tumor in women that has a high recurrence rate. Our aim is to propose a prognostic index (PI) model for predicting the long-term recurrence risk of uterine leiomyoma (UL). METH…

2021
Journal of oncology ·doi:10.1155/2021/8859554

BackgroundOvarian cancer (OC) is one of the leading lethal gynecologic cancers of women around the world. More than 70% of patients are diagnosed with stage III or IV with poor outcome. This is partly because of lacking early effective scre…

preprint 2021
·doi:10.26434/chemrxiv.14131775.v1

Endometriosis(EM)is a non-cancerous and intractable disease in clinic due to the ambiguity of its etiology and mechanism. Surgical removal of the lesions is more efficient method for EM treatment compared with pharmacological intervention. …

2021
Genomics ·doi:10.1016/j.ygeno.2021.08.012

The high rate of SARS-CoV-2 infection poses a serious threat to public health. Previous studies have suggested that SARS-CoV-2 can infect human ovary, the core organ of the female reproductive system. However, it remains unclear which type …

2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00836-8

BackgroundSynchronization of follicles is key to improving ovulation stimulation with the gonadotropin-releasing hormone (GnRH) antagonist protocol. GnRH antagonist administration in the early follicular phase can quickly decrease gonadotro…